Sandia Investment Management’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
TCM
DTC
CAM
GPP
VA
CC
NCM
SB
Sandia Investment Management's ABVX Position: Q3 2024 in Review
Sandia Investment Management sold out of Abivax (ABVX) in Q3 2024, closing a stake of 7,500 shares — an estimated $99.2K sold.
Sandia Investment Management first reported a position in ABVX in Q4 2023 and held it in 3 quarters. The position peaked at $214K in Q4 2023. 40 funds tracked by Wall St. Rank hold ABVX as of Q3 2024.
- Sandia Investment Management reported no remaining Abivax position as of Q3 2024 after selling out during the quarter.
- Sandia Investment Management sold 7,500 Abivax shares in Q3 2024, an estimated $99.2K.
- Sandia Investment Management first reported a position in Abivax in Q4 2023 and held it in 3 quarters.
- Sandia Investment Management's Abivax position peaked at $214K in Q4 2023.
- 40 funds tracked by Wall St. Rank held Abivax as of Q3 2024.
Based on Sandia Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.